Литература

1. Круглова Л. С., Иконникова Е. В. Гиперпигментация кожи: современные взгляды на этиологию и патогенез (часть 1). Российский журнал кожных и венерических болезней. 2017, № 20(3): 178-83.
2. Arrowitz C., Schoelermann A. M., Mann T., et al. Effective tyrosinase inhibition by thiamidol results in significant improvement of mild to moderate melasma. J Invest Dermatol. 2019, № 139(8): 1691-68.
3. Mann T., Gerwat W., Batzer J., et al. Inhibition of human tyrosinase requires molecular motifs distinctively different from mushroom tyrosinase. J Invest Dermatol. 2018, № 138(7): 1601-68.
4. Калинина Е. В., Чернов Н. Н., Новичкова М. Д. Успехи биологической химии. 2014, т. 54: 299–348.
5. Philipp-Dormston W. G., Vila Echagüe A., Pérez Damonte S. H., et al. Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study. Int J Cosmet Sci. 2020, № 42(4): 377-87.